Prof. Abby Lippman: Let me broaden that, and that is in terms of the bill. What I didn't get to say, when I was reading from my notes, was that even in terms of the regulatory body, I don't think there should be anybody appointed to that who has a conflict of interest—in other words, who's going to have any financial gain from being on that regulatory body.
Mme Abby Lippman: Ce que je ne vous ai pas dit, quand je lisais mes notes, c'est que, même du point de vue de l'organisme de réglementation, je ne pense pas que l'on devrait nommer qui que ce soit qui puisse avoir un conflit d'intérêts—autrement dit, qui puisse tirer un gain financier de son appartenance à l'organisme de réglementation.
